Skip to content

Alinity 07P5121

by Abbott Ireland

Alinity 07P5121 is a Class II device made by Abbott Ireland, listed in FDA GUDID since 31 May 2018 (UDI-DI 00380740160616), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00380740160616 UDI-DI Date31 May 2018ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Alinity
Generic name
Human chorionic gonadotropin beta-core fragment IVD, kit, chemiluminescent immunoassay
Model / Ref / Catalog
07P5121
Primary DI / UDI-DI
00380740160616
FDA product code
DHA
GMDN term
Human chorionic gonadotropin beta-core fragment IVD, kit, chemiluminescent immunoassay
Device class
Class II
Regulation number
862.1155
GUDID distribution status
In Commercial Distribution

Other devices from Abbott Ireland

See all devices from Abbott Ireland →

Properties

  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)